Eotaxin-3 in Churg-Strauss syndrome: A clinical and immunogenetic study

Rheumatology

Volumn 50, Issue 10, 2011, Pages 1823-1827

  Zwerina, Jochen ^a   Bach, Christian ^b   Martorana, Davide ^c   Jatzwauk, Maria ^b   Hegasy, Guido ^d   Moosig, Frank ^e   Bremer, Jan ^e   Wieczorek, Stefan ^f   Moschen, Alexander ^g   Tilg, Herbert ^g   Neumann, Thomas ^h   Spriewald, Bernd M ^b   Schett, Georg ^a   Vaglio, Augusto ^c  

^a Department of Internal Medicine 3 and Institute for Clinical Immunology ^*  (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF PARMA   (Italy)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Biomarker; Ccl26; Churg Strauss syndrome; Diagnosis; Eoxtaxin 3

Indexed keywords

EOTAXIN 3;

ARTICLE; ASTHMA; BLOOD SAMPLING; CHURG STRAUSS SYNDROME; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EOSINOPHIL; EX VIVO STUDY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RELAPSE; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CHEMOKINES, CC; CHURG-STRAUSS SYNDROME; COLITIS, ULCERATIVE; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPEREOSINOPHILIC SYNDROME; IMMUNOGENETIC PHENOMENA; PARASITIC DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 80053137236     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq445     Document Type: Article

References (17)

1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951;27: 277-301.
2. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 1999;78: 26-37.
3. Sable-Fourtassou R, Cohen P, Mahr A et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005;143:632-8.
4. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982;97: 78-92.
5. Wolfe MS. Eosinophilia in the returning traveler. Med Clin North Am 1999;83:1019-32.
6. Sinico RA, Di Toma L, Maggiore U et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005;52: 2926-35.
7. Polzer K, Karonitsch T, Neumann T et al. Eotaxin-3 is involved in Churg-Strauss syndrome-a serum marker closely correlating with disease activity. Rheumatology 2008;47:804-8.
8. Kitaura M, Suzuki N, Imai T et al. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 1999; 274:27975-80.
9. Berkman N, Ohnona S, Chung FK, Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 2001;24:682-7.
10. Chae SC, Lee YC, Park YR et al. Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil. Biochem Biophys Res Commun 2004;320:131-7.
11. Chae SC, Park YR, Oh GJ, Lee JH, Chung HT. The suggestive association of eotaxin-2 and eotaxin-3 gene polymorphisms in Korean population with allergic rhinitis. Immunogenetics 2005;56:760-4.
12. Chae SC, Park YR, Shim SC, Lee IK, Chung HT. Eotaxin-3 gene polymorphisms are associated with rheumatoid arthritis in a Korean population. Hum Immunol 2005;66: 314-20.
13. Blanchard C, Wang N, Stringer KF et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006;116:536-47.
14. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 1975;54:1-27.
15. Vaglio A, Martorana D, Maggiore U et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 2007;56:3159-66.
16. Wieczorek S, Hellmich B, Gross WL, Epplen JT. Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al. Arthritis Rheum 2008;58:329-30.
17. Wieczorek S, Hellmich B, Arning L et al. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis. Arthritis Rheum 2008;58:1839-48.